Once a common procedure, left ventriculography’s role in assessing heart disease has evolved considerably over the decades, leading to significant variations in use. A new expert consensus statement e-published by the Society for Cardiovascular Angiography and Interventions (SCAI) recommends optimal uses for left ventriculography, with the goal of more standardized use of the test and improved quality of care for cardiac patients.

Siemens Healthcare announces the availability of the Acuson X600 – a new ultrasound system with advanced technologies migrated from premium Siemens systems and workflow efficiencies for clinical applications in general imaging, obstetrics and gynecology and cardiology.

The hospitals of UnityPoint Health — Des Moines offering adult cardiac services recently began using analytics software by Lumedx. The software offers flexible reports based on wide range of granular data.


There are several hemostasis devices that can help cath labs improve efficiency by reducing nursing time in the recovery area, speeding the post-procedural time to patient ambulation and enabling same day percutaneous coronary interventions (PCI).  There are three types of devices to aid hemostasis of arteriotomy access site punctures — vascular closure devices (VCD), compression devices and bandages coated with agents to speed the clotting cascade.
McKesson Cardiology, cardiac PACS, CVIS

For any cardiology department looking to upgrade or replace its cardiovascular picture archiving and communications system (cardiac PACS), or cardiovascular information system (CVIS), the main questions that should be asked are related to integration and interoperability. These are key to leveraging health IT investments to achieve improved efficiency, help cut costs and 
accommodate increased patient volume.
 

The desire to guide product development and remain on the leading edge of cardiac care led Shannon to become a beta testing site for McKesson Cardiology 13.1, which extends remote access with the ability for physicians to view ECG waveforms and results on iPads. 

The key take away messages from the 26th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium were bioresorable stents and transcatheter valve technologies will likely become primary interventional tools in the near future. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now